GTx to Host Conference Call and Webcast to Provide Update on Status of Toremifene 80 mg New Drug Application

* Reuters is not responsible for the content in this press release.

Fri Oct 30, 2009 4:22pm EDT 

http://www.businesswire.com/news/home/20091030005977/en

MEMPHIS, Tenn.--(Business Wire)--
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and
webcast on Monday, November 2, 2009 to provide an update regarding the New Drug
Application for toremifene 80 mg to reduce fractures in men with prostate cancer
on androgen deprivation therapy. 

Conference Call

GTx will host the conference call and webcast on Monday, November 2, 2009 at
9:00 a.m. Eastern Time. To listen to the conference call, please dial:

 --    888-396-2369 from the United States and Canada or  
 --    617-847-8710 (International).                      
       The access code for the call is 59484869.          


A playback of the call will be available beginning Monday at 11:00 a.m. Eastern
Time through November 16, 2009, and may be accessed by dialing:

 --    888-286-8010 from the United States and Canada or   
 --    617-801-6888 (International)                        
       The reservation number for the replay is 47774982.  


Additionally, you may access the live and subsequently archived webcast of the
conference call from the Investor Relations section of the Company`s website at
http://www.gtxinc.com.

GTx, Inc.
McDavid Stilwell, 901-507-2667
Director, Corporate Communications & Financial Analysis 



Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.